{"id":1367,"date":"2020-05-04T18:32:18","date_gmt":"2020-05-04T17:32:18","guid":{"rendered":"https:\/\/ppra.inserm.dev-mlcom.net\/forces-de-recherche-francaises\/les-reseaux-de-surveillance\/"},"modified":"2021-05-20T11:00:07","modified_gmt":"2021-05-20T10:00:07","slug":"the-surveillance-networks","status":"publish","type":"page","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/french-research-forces\/the-surveillance-networks\/","title":{"rendered":"The surveillance networks"},"content":{"rendered":"\n

The human health surveillance networks: One of the missions of the national public health agency <\/strong>(Sant\u00e9 publique France<\/a>),\u00a0is to coordinate surveillance, studies and expertise in antimicrobial resistance in the three healthcare sectors (including healthcare, medical, social and point of care establishments). The agency is supported by regional partners, the Centres for Prevention of Healthcare-Associated Infections (Centres de pr\u00e9vention des infections associ\u00e9es aux soins<\/em>,\u00a0 CPias<\/a>), some of which have been selected to coordinate national missions following calls for projects. These coordinator centres are grouped within the Network for the Prevention and Surveillance of Healthcare-Associated Infections (R\u00e9seau de pr\u00e9vention et de surveillance des infections associ\u00e9es aux soins<\/em>, R\u00e9Pias<\/u><\/a>). \n \n\u00a0 \n \n\u2013\u00a0\u00a0\u00a0\u00a0CPias for the Grand-Est region<\/strong>, in conjunction with the CPias for Nouvelle Aquitaine and the Limoges University Hospital Microbiology Department, is tasked with the nationwide surveillance and prevention of antibiotic resistance in hospitals (Surveillance et la pr\u00e9vention de l\u2019antibior\u00e9sistance en \u00e9tablissements de sant\u00e9,<\/em> SPARES<\/a>). The objectives of SPARES are to deploy and coordinate the surveillance of antibiotic consumption and bacterial resistance, as well as evaluate the prevention of cross-transmission of multi-drug resistant and highly-resistant bacteria in hospitals. The surveillance is based on ConsoRes,a shared tool for recording data from a healthcare application software. All healthcare institutions can take part in the initiative. \n \n \n\u2013\u00a0\u00a0\u00a0\u00a0The national mission for the surveillance<\/strong> of antibiotic resistance and healthcare-associated infections in community medicine and medico-social institutions (Surveillance et Pr\u00e9vention de la R\u00e9sistance aux antibiotiques et des Infections associ\u00e9es aux soins en soins de ville et secteur m\u00e9dico-social, <\/em>Primo<\/a>) is driven by\u00a0CPias Pays-de-La-Loire<\/a>\u00a0and\u00a0CPias Grand Est<\/a>.\u00a0 The tool, e-Medqual ville, serves as a basis for monitoring resistance and all diagnostic laboratories wishing to do so can take part. The surveillance concerns data on resistance by Escherichia coli<\/em>, Staphylococcus aureus,<\/em> Enterobacter cloacae<\/em>, Enterobacter aerogenes, Klebsiella pneumoniae<\/em>, and Klebsiella oxytoca<\/em>. \n \n \n\u2013\u00a0\u00a0\u00a0In addition to antibiotic sales analysis by the National Agency for Medicines and Health Products Safety (Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9<\/em>, ANSM),\u00a0Sant\u00e9 publique France monitors nation-wide antibiotics consumption at the general practitioner level<\/strong>, with measurements based on national health insurance reimbursement data (National Health Data System – SNDS). \n \n \nThe principal national and regional indicators of antibiotic resistance and consumption can be freely consulted in GEODES<\/a>, the interactive portal of Sant\u00e9 publique France. More comprehensive annual surveillance reports can be consulted on the Sant\u00e9 publique France<\/u> website. \n \n \nThe clinical research networks:<\/u><\/strong> \n